PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsOlympus Biotech
Olympus Biotech
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
OpgenraEptotermin alfa2009-02-19
Spondylolisthesis
,
Tibial fractures
OsigraftEptotermin alfa2001-05-17
Spondylolisthesis
,
Tibial fractures
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Eptotermin alfa
spondylolisthesis
,
intervertebral disc degeneration
Trafermin
periodontitis
,
diabetic foot
,
ulcer
,
foot ulcer
,
tympanic membrane perforation
,
alveolar bone loss
,
periodontal attachment loss
Aspartame
healthy volunteers/patients
,
colorectal neoplasms
,
chronic renal insufficiency
,
kidney diseases
,
sickle cell anemia
,
knee osteoarthritis
,
osteoarthritis
,
heart failure
,
lung neoplasms
,
ovarian neoplasms
,
sarcoma
,
ovarian epithelial carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
laryngeal neoplasms
,
opioid-related disorders
,
covid-19
,
coronavirus infections
,
carcinoma
,
neoplasms
,
urinary bladder neoplasms
,
brain neoplasms
,
serous cystadenocarcinoma
,
glioma
,
neurofibromatosis 2
,
acoustic neuroma
,
meningioma
,
ependymoma
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
neurilemmoma
,
body weight
,
cystic fibrosis
,
melanoma
,
biliary tract neoplasms
,
rare diseases
,
invasive hydatidiform mole
,
non-muscle invasive bladder neoplasms
,
non-hodgkin lymphoma
,
b-cell chronic lymphocytic leukemia
,
mantle-cell lymphoma
,
b-cell lymphoma
,
b-cell leukemia
,
diabetes mellitus
,
chronic obstructive pulmonary disease
,
obesity
,
lung diseases
,
obstructive lung diseases
,
non-small-cell lung carcinoma
,
asthma
,
pulmonary eosinophilia
,
overweight
,
weight loss
,
hyperkalemia
,
endometrial neoplasms
,
borderline personality disorder
,
personality disorders
,
churg-strauss syndrome
,
eosinophilic granuloma
,
type 2 diabetes mellitus
,
breast neoplasms
,
fibrosis
,
inflammation
,
myocarditis
,
endomyocardial fibrosis
,
postoperative pain
,
depression
,
major depressive disorder
,
depressive disorder
Bevifimod
sickle cell anemia
,
neoplasms
,
colonic neoplasms
,
adenocarcinoma
,
systemic lupus erythematosus
,
colorectal neoplasms
,
agammaglobulinemia
,
primary immunodeficiency diseases
,
von willebrand diseases
,
alzheimer disease
,
graft vs host disease
,
thrombocytopenic purpura idiopathic
,
protein c deficiency
,
leukemia
,
myeloid leukemia acute
,
non-hodgkin lymphoma
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
hodgkin disease
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
mantle-cell lymphoma
,
myeloid leukemia chronic-phase
,
large b-cell lymphoma diffuse
,
myeloid leukemia accelerated phase
,
burkitt lymphoma
,
large-cell lymphoma immunoblastic
,
hemophilia b
,
thrombotic thrombocytopenic purpura
,
chronic obstructive pulmonary disease
,
dementia
,
mucocutaneous lymph node syndrome
,
immunologic deficiency syndromes
,
hemophilia a
,
alpha 1-antitrypsin deficiency
,
disease
,
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use